The post SushiSwap CEO steps down as Synthesis invests $3.3M in struggling DEX appeared on BitcoinEthereumNews.com. Decentralized exchange SushiSwap announced a leadership transition today,1 December, with Synthesis founder Alex McCurry acquiring over 10 million SUSHI tokens and assuming control of the protocol.  The move comes as the once-prominent DEX grapples with a catastrophic 99% collapse in total value locked and underwhelming revenue figures. Source: X Jared Grey, who led SushiSwap through three turbulent years marked by SEC subpoenas and governance controversies, is stepping down to an advisory role.  The announcement positions the change as a growth opportunity, citing profitability and ambitious expansion plans. However, on-chain data and financial statements paint a starkly different picture. The numbers behind SushiSwap SushiSwap’s total value locked has plummeted from over $8 billion in early 2022 to just $101.79 million currently, representing a 98.7% decline.  The protocol’s TVL chart from DefiLlama shows flatline activity essentially since 2023. There has been no meaningful recovery despite multiple restructuring attempts and product launches. Source: DefiLlama The company claims to have generated over $10 million in revenue in 2024. 2025 revenue, according to data, totals approximately $4.5 million across all quarters. Q1 brought in just $337,000, Q2 at $195,000, Q3 at $1.37 million, and Q4 projected at $2.63 million.  The discrepancy suggests the $10 million figure may combine fees with revenue or represent forward-looking projections rather than realized income. McCurry’s investment, although significant in terms of token count, amounts to roughly $3.34 million at current prices, with SUSHI trading at $0.3341.  The token has crashed 70% since its July peak near $1.10 and remains down 98.5% from its March 2021 all-time high of $23. Source: TradingView Market reality sets in The timing of Grey’s departure raises questions about the sustainability of SushiSwap. The DEX recently announced a roadmap, which includes expansion to Solana.  SushiSwap faces intense competition from dominant players like Uniswap while struggling to… The post SushiSwap CEO steps down as Synthesis invests $3.3M in struggling DEX appeared on BitcoinEthereumNews.com. Decentralized exchange SushiSwap announced a leadership transition today,1 December, with Synthesis founder Alex McCurry acquiring over 10 million SUSHI tokens and assuming control of the protocol.  The move comes as the once-prominent DEX grapples with a catastrophic 99% collapse in total value locked and underwhelming revenue figures. Source: X Jared Grey, who led SushiSwap through three turbulent years marked by SEC subpoenas and governance controversies, is stepping down to an advisory role.  The announcement positions the change as a growth opportunity, citing profitability and ambitious expansion plans. However, on-chain data and financial statements paint a starkly different picture. The numbers behind SushiSwap SushiSwap’s total value locked has plummeted from over $8 billion in early 2022 to just $101.79 million currently, representing a 98.7% decline.  The protocol’s TVL chart from DefiLlama shows flatline activity essentially since 2023. There has been no meaningful recovery despite multiple restructuring attempts and product launches. Source: DefiLlama The company claims to have generated over $10 million in revenue in 2024. 2025 revenue, according to data, totals approximately $4.5 million across all quarters. Q1 brought in just $337,000, Q2 at $195,000, Q3 at $1.37 million, and Q4 projected at $2.63 million.  The discrepancy suggests the $10 million figure may combine fees with revenue or represent forward-looking projections rather than realized income. McCurry’s investment, although significant in terms of token count, amounts to roughly $3.34 million at current prices, with SUSHI trading at $0.3341.  The token has crashed 70% since its July peak near $1.10 and remains down 98.5% from its March 2021 all-time high of $23. Source: TradingView Market reality sets in The timing of Grey’s departure raises questions about the sustainability of SushiSwap. The DEX recently announced a roadmap, which includes expansion to Solana.  SushiSwap faces intense competition from dominant players like Uniswap while struggling to…

SushiSwap CEO steps down as Synthesis invests $3.3M in struggling DEX

Decentralized exchange SushiSwap announced a leadership transition today,1 December, with Synthesis founder Alex McCurry acquiring over 10 million SUSHI tokens and assuming control of the protocol. 

The move comes as the once-prominent DEX grapples with a catastrophic 99% collapse in total value locked and underwhelming revenue figures.

Source: X

Jared Grey, who led SushiSwap through three turbulent years marked by SEC subpoenas and governance controversies, is stepping down to an advisory role. 

The announcement positions the change as a growth opportunity, citing profitability and ambitious expansion plans. However, on-chain data and financial statements paint a starkly different picture.

The numbers behind SushiSwap

SushiSwap’s total value locked has plummeted from over $8 billion in early 2022 to just $101.79 million currently, representing a 98.7% decline. 

The protocol’s TVL chart from DefiLlama shows flatline activity essentially since 2023. There has been no meaningful recovery despite multiple restructuring attempts and product launches.

Source: DefiLlama

The company claims to have generated over $10 million in revenue in 2024. 2025 revenue, according to data, totals approximately $4.5 million across all quarters. Q1 brought in just $337,000, Q2 at $195,000, Q3 at $1.37 million, and Q4 projected at $2.63 million. 

The discrepancy suggests the $10 million figure may combine fees with revenue or represent forward-looking projections rather than realized income.

McCurry’s investment, although significant in terms of token count, amounts to roughly $3.34 million at current prices, with SUSHI trading at $0.3341. 

The token has crashed 70% since its July peak near $1.10 and remains down 98.5% from its March 2021 all-time high of $23.

Source: TradingView

Market reality sets in

The timing of Grey’s departure raises questions about the sustainability of SushiSwap. The DEX recently announced a roadmap, which includes expansion to Solana. 

SushiSwap faces intense competition from dominant players like Uniswap while struggling to recapture the liquidity and user base that once made it a DeFi powerhouse. 

Whether new leadership and capital injection can reverse the protocol’s multi-year decline remains uncertain as the DEX landscape continues to consolidate around established winners.

Final Thoughts

  • SushiSwap’s 99% TVL collapse from $8B to $100M reveals a protocol in severe decline, not the growth story presented in today’s announcement.
  • The actual investment size of $3.34M appears modest for a turnaround effort, raising questions about whether this capital injection can meaningfully reverse years of deterioration.
Next: VIRTUAL loses 45% in a year – Can THIS stop the bleeding?

Source: https://ambcrypto.com/sushiswap-ceo-steps-down-as-synthesis-invests-3-3m-in-struggling-dex/

Market Opportunity
ALEX Lab Logo
ALEX Lab Price(ALEX)
$0.00123
$0.00123$0.00123
+1.65%
USD
ALEX Lab (ALEX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26